Education
About Us
Working with TipRanks
Follow Us
PolyPeptide Group AG (CH:PPGN)
:PPGN
Total Valuation
PolyPeptide Group AG has a market cap or net worth of CHF706.87M. The enterprise value is ―.
Market CapCHF706.87M
Enterprise Value―
Share Statistics
PolyPeptide Group AG has 33,125,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,125,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PolyPeptide Group AG’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -1.33%.
Return on Equity (ROE)-0.05
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-1.33%
Return on Capital Employed (ROCE)-0.01
Revenue Per Employee248.67K
Profits Per Employee-14.36K
Employee Count1,362
Asset Turnover0.45
Inventory Turnover2.05
Valuation Ratios
The current PE Ratio of PolyPeptide Group AG is -50.85. PolyPeptide Group AG’s PEG ratio is 0.82.
PE Ratio-50.85
PS Ratio0.00
PB Ratio1.77
Price to Fair Value2.78
Price to FCF260.67
Price to Operating Cash Flow7.07
PEG Ratio0.82
Income Statement
In the last 12 months, PolyPeptide Group AG had revenue of 338.69M and earned -19.56M in profits. Earnings per share was -0.59.
Revenue338.69M
Gross Profit39.27M
Operating Income-7.36M
Pretax Income-18.14M
Net Income-19.56M
EBITDA28.42M
Earnings Per Share (EPS)-0.59
Cash Flow
In the last 12 months, operating cash flow was 36.48M and capital expenditures -52.90M, giving a free cash flow of -16.41M billion.
Operating Cash Flow36.48M
Free Cash Flow-16.41M
Free Cash Flow per Share-0.50
Dividends & Yields
PolyPeptide Group AG pays an annual dividend of CHF0.3, resulting in a dividend yield of ―
Dividend Per ShareCHF0.3
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.31
52-Week Price Change-34.56%
50-Day Moving Average18.12
200-Day Moving Average24.98
Relative Strength Index (RSI)65.13
Average Volume (3m)35.42K
Important Dates
PolyPeptide Group AG upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.
Last Earnings DateMar 11, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend DateApr 28, 2022
Financial Position
PolyPeptide Group AG as a current ratio of 1.69, with Debt / Equity ratio of 26.35%
Current Ratio1.69
Quick Ratio0.94
Debt to Market Cap0.07
Net Debt to EBITDA0.91
Interest Coverage Ratio-0.53
Taxes
In the past 12 months, PolyPeptide Group AG has paid 1.42M in taxes.
Income Tax1.42M
Effective Tax Rate-0.08
Enterprise Valuation
PolyPeptide Group AG EV to EBITDA ratio is 35.92, with an EV/FCF ratio of 419.89.
EV to Sales3.01
EV to EBITDA35.92
EV to Free Cash Flow419.89
EV to Operating Cash Flow11.42
Balance Sheet
PolyPeptide Group AG has CHF95.71M in cash and marketable securities with €113.66M in debt, giving a net cash position of CHF17.96M billion.
Cash & Marketable SecuritiesCHF95.71M
Total Debt€113.66M
Net CashCHF17.96M
Net Cash Per ShareCHF0.54
Tangible Book Value Per ShareCHF10.39
Margins
Gross margin is 11.59%, with operating margin of -2.17%, and net profit margin of -5.78%.
Gross Margin11.59%
Operating Margin-2.17%
Pretax Margin-5.36%
Net Profit Margin-5.78%
EBITDA Margin8.39%
EBIT Margin-1.27%
Analyst Forecast
The average price target for PolyPeptide Group AG is CHF31.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetCHF31.00
Price Target Upside44.86% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast3.15%
EPS Growth Forecast62.88%